Zantac Campaign

Get Started with Zantac Mass Tort Leads Today!

Ask about our criteria standards for cases like these and others.

Over 100,000 cases have been filed by people who developed cancer after taking the drug Zantac as directed to treat heartburn. According to the U.S. Food And Drug Administration, “… the impurity in some ranitidine products increases over time and when stored at higher than room temperatures may result in consumer exposure to unacceptable levels of this impurity.” Along those lines, the manufacturer of the drug found in studies that the ranitidine in their product could build up over time and develop levels of N-nitrosodimethylamine (NDMA) 3,000 to 26,000 times higher than the amounts considered safe.

The History of Zantac

Zantac was approved as a prescription treatment for heartburn in adults, children, and infants by the FDA in 1983. The primary ingredient in the medication was ranitidine. In 1997, the parent company’s manufacturing patent expired, allowing companies other than Glaxo to produce generic versions. In 2004, an over-the-counter version was released. It is claimed that manufacturers of the drug were aware of the issues with the toxic buildup over time but failed to disclose this information publicly. In 2019, a class action lawsuit was filed by Zantac users who had been diagnosed with cancer. In 2020, the FDA recalled all Zantac, which was removed from store shelves.

The Impact of NDMA on the Body

NDMA is a known carcinogenic industrial by-product used in aviation fuel. When the consumers took Zantac, the unstable molecules in ranitidine were converted to NDMA and were absorbed by the liver, increasing the risk of liver cancer. The toxic material can also be absorbed by the lungs and kidneys, causing harm to these vital organs.

With short-term use of Zantac, the harm was typically found to be limited to live damage, including scarring and liver fibrosis. Long-term use of Zantac was determined to be linked to tumors in the liver, kidneys, and lungs. Those who used Zantac were often subject to many NDMA overexposure symptoms that caused them to seek medical care. Those symptoms include:

• Headaches
• Fever
• Vomiting
• Nausea
• Diarrhea
• Abdominal cramps
• Dizziness
• Jaundice
• Enlarged liver
• GI hemorrhage

In addition to tumors and cancer, some patients experienced irregular or rapid heartbeat, known as arrhythmia or tachycardia, nervous system disorders, hepatitis, increased risk of pneumonia, low blood platelet levels, hair loss, and skin rashes.

What Early Case Results Mean for Zantac Class Actions

The outcome of early Zantac lawsuits will not be considered precedents. However, the results of those cases can motivate the decision to negotiate a settlement rather than take the matter to court and face added fees and expenses.

WHAT LAW FIRMS SAY ABOUT US

We offer custom solutions for law firms searching to streamline their lead acquisition.

Ask us how our intake department partners with yours

Request a Free Consultation

We’re here to meet all your case acquisition needs. For more information or to ask any questions, please reach out to us at any time. Contact us today, and we’ll be in touch within 24 hours.